- Woman in her late 20s with bipolar I, PTSD, and anorexia nervosa, binge-purge subtype, showed minimal response to multiple PTSD medication trials.
- Following a stellate ganglion block, CAPS-5 and PCL-5 scores decreased, indicating symptomatic improvement though residual symptoms persisted.
- This case supports consideration of SGB as a potential off-label treatment option for treatment-resistant PTSD, warranting further study.
Cureus. 2026 Oct 14;18(10):e117912. doi: 10.7759/cureus.117912. eCollection 2026 Oct.
ABSTRACT
Post-traumatic stress disorder (PTSD) is a psychiatric condition that can develop following exposure to traumatic events and is characterized by intrusive memories, avoidance, negative changes in mood and cognition, and heightened arousal. A woman in her late 20s with bipolar I disorder, PTSD, and anorexia nervosa, binge-purge subtype, demonstrated minimal response to multiple medication trials targeting PTSD symptoms. Following administration of a stellate ganglion block (SGB), symptom scores decreased on the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) and the PTSD Checklist for DSM-5 (PCL-5), although residual symptoms remained. This case highlights the potential role of SGB as an off-label therapeutic option for PTSD.
PMID:43032182 | PMC:PMC13760664 | DOI:10.7759/cureus.117912
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
⭐ My Revision List

